Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00329732 · ClinicalTrials.gov registry record · NA
Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks
A NA study, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00329732 is a NA study that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 2 participants.
The verdict
NCT00329732, a NA study, was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Greater Occipital Nerve Blocks (GONB) are a common procedure used for the treatment of headache. The GONB procedure involves a series of injections into the greater occipital nerve (a spinal nerve located at the back of your head). The purpose of this study is to determine whether GONB is effective for the treatment of prolonged migraine attacks. This study is placebo controlled, which means that half of the patients participating will receive injections of active study drug (lidocaine plus bupivicaine) and half of the patients will receive injections of saline (placebo). The study is also blinded which means that neither you nor the study staff will know whether you received active study drug or placebo. The study remains blinded only for the first 30 minutes, at which point additional treatments (including GONB) can be administered at the discretion of your treating physician. 40 patients are expected to participate in this research study. This study is being conducted at Thomas Jefferson University only.
Interventions
- DRUG Saline placebo
- DRUG 0.5% bupivicaine and 2% lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2006-03 |
| Est. Completion | 2006-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00329732
The ClinicalTrials.gov registry entry for NCT00329732 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline placebo is the first listed.
NCT00329732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00329732 about?
NCT00329732 is a clinical study titled "Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks". Greater Occipital Nerve Blocks (GONB) are a common procedure used for the treatment of headache. The GONB procedure involves a series of injections into the greater occipital nerve (a spinal nerve located at the back of your head). The purpose of this study is to determine whether GONB is effective ...
What is the current status of trial NCT00329732?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2006-03. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00329732?
The interventions under investigation include: Saline placebo (DRUG), 0.5% bupivicaine and 2% lidocaine (DRUG).
Who is sponsoring clinical trial NCT00329732?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.